- Nachrichtendetail
-
28.03.2024 12:06:41 - dpa-AFX: *GILEAD SCIENCES, XILIO THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP TUMOR-ACTIVATED IL-12 PROGRAM, XTX301
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GILEAD SCIENCES DL-,001 | 885823 | Frankfurt | 58,640 | 30.05.24 17:17:47 | +0,130 | +0,22% | 0,000 | 0,000 | 58,420 | 58,510 |
